Phase 1 XG005-03 Topical Study

NCT04283474 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: XG005-03
DRUG: Placebo

Sponsor

Xgene Pharmaceutical Group